-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Raised to $60 at Raymond James
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Raised to $50 at Leerink Partners
-
-
-
-
-
-
-
Scholar Rock targets 2026 apitegromab BLA resubmission and launch
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Lowered to $44 at Truist Securities
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Lowered to $48 at Leerink Partners
-
-
-
-
-
-
-
Raymond James Adjusts Analysts Current Favorites List
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Scholar Rock (SRRK)
-
443,903 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

